all
Today news
Donald Trump
Donald John Trump (born June 14, 1946) is the 45th and current president of the United States. Before entering politics, he was a businessman and television personality. Trump was born and raised in Queens, a borough of New York City, and received a bachelor's degree in economics from the Wharton School. He took charge of his family's real-estate business in 1971, renamed it The Trump Organization, and expanded its operations from Queens and Brooklyn into Manhattan. The company built or renovated skyscrapers, hotels, casinos, and golf courses. Trump later started various side ventures, mostly by licensing his name. He bought the Miss Universe brand of beauty pageants in 1996, and sold it in 2015. He produced and hosted The Apprentice, a reality television series, from 2003 to 2015. As of 2020, Forbes estimated his net worth to be $2.1 billion.[
The same in other media

HIV: het hele verhaal door Angela Groothuizen en Loiza Lamers

Reading now: 396
www.gaynews.nl

Op 1 december 2022, Wereld Aids Dag, komt BNR met een nieuwe serie: Uitgedokterd. In het eerste seizoen enlsquo;Uitgedokterd: HIV, de hemel kan wachtenenrsquo;, nemen Angela Groothuizen en Loiza Lamers de luisteraar mee door de wanhoop van de roerige jaren enlsquo;80, de politieke spelletjes en de strijd van long term survivors naar de zo gehoopte doorbraak.

Read more on gaynews.nl
The website meaws.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

23.12 / 04:51
News Treatment Twice-Yearly HIV Treatment Approved for Those With Drug Resistance
The U.S. Food and Drug Administration approved the drug Sunlenca (lenacapavir), produced by Gilead Sciences, in combination with other antiretrovirals for the treatment of HIV-1 infection in heavily treatment-experienced (HTE) adults with multi-drug resistant (MDR) HIV-1 infection.Sunlenca offers a new, twice-yearly treatment option for HIV-positive adults that is not adequately controlled by their current regimen.“Today’s approval ushers in a new class of antiretroviral drugs that may help patients with HIV who have run out of treatment options,” Debra Birnkrant, M.D., said in a press release from the FDA.
DMCA